Hence, they came to the conclusion that BCR-ABL directly regulates the CCN3 secretion in the CML cells where the levels of cellular CCN3 is reduced. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.